A recent multi-site study found Ibex Breast reduced evaluation time & improved pathologists’ accuracy in detecting microinvasive and T1a breast carcinomas, with concurrent extended DCIS and enriched for potentially confounding lesions. Join us on Sunday, Sept 7th at #ECP2025 for

The team at CorePlus have been leading the world in adoption of digital pathology and AI for the last five years. In their latest publication, they shared 3+ years of real-world experience using Ibex's AI for prostate cancer diagnosis. The data showed the algorithm had a NPV of

"Anything we can do to alleviate concern and get answers into patient and clinicians hands quicker, and actually get the correct answers with the highest possible quality, is what Alverno has always been about" says Sam Terese, Alverno Laboratories CEO on why they chose to use

In just a few weeks at ECP, Dr. Elena Provenzano of @CUH_NHS will present data from a real-world prospective study across 5 @NHSuk hospitals (4,500 cases+) showing that Ibex Breast is highly accurate in identifying benign, cancer, invasive cancer, and DCIS cases. She'll also

In a @KLASresearch Report, 100% of Ibex customers said they would purchase our solution again. We're honored to support pathologists around the world with #AI-powered tools to assist #cancer diagnosis. Review the report for more direct customer feedback:

How can AI assist pathologists reviewing prostate biopsies? @harshthaker of @UTMB_Pathology reviews several cases, shares his team's digital pathology journey & presents the benefits they are seeing after adopting Ibex's AI-powered tools at an academic medical center during his

With more than 2 million new cases of breast cancer each year, accurate and timely diagnosis is instrumental in getting patients the care they need. Ibex's #AI solution for breast tissue supports pathologists with a broad range of detection capabilities including: IDC vs. ILC,

It's hard to believe that we're only a month away from #ECP2025 in Vienna, Austria! We have a robust clinical program, opportunities to hear directly from Ibex users, and our team will be providing live demos of Ibex's upgraded AI platform at booth #120. Check out our event page

This month at the Urological Association of Asia's Annual Conference, Dr. Santa Rosario of CorePlus will share his teams' knowledge from years of experience using AI in routine care. Join him on August 17th in Taipei to learn firsthand from a global leader in digital pathology!

Reviewing the high volumes of tissue in TURPs cases can be labor-intensive for pathologists. Ibex Prostate allows pathologists to triage cases according to case-level tags, flags high-priority slides and identifies critical regions of interest for pathologists' review.

"We’re helping clinicians deliver more precise prostate cancer care by streamlining complex workflows and delivering the insights they need to support precise diagnosis and expand options for minimally invasive treatments," said Martign Hartjes, business leader of clinical.

With cancer cases rising and the number of pathologists decreasing, Dr. David Bailey and Dr. Eliabeth Astall of the @NWAngliaFT share the improvements they've seen in workflow efficiency, diagnostic confidence and employee satisfaction since implementing Ibex's platform into

Accurate assessment of HER2 is critical for informing treatment decisions for metastatic breast cancer. Ibex's fully automated Ibex Breast HER2 solution helps to improve pathologists' scoring accuracy and reproducibility. Learn more about Ibex Breast HER2 here:

A recent peer-reviewed study conducted at @OSUWexMed shows that using Ibex improves pathologists' diagnostic accuracy to 100% & reduces review times by up to 23%. These results highlight how Ibex Breast is transforming breast cancer diagnostics – supporting pathologists in

Next week @divyasrivast of @CityStGeorges will present new data from a real-world prospective study across 5 @NHSuk hospitals (4,500 cases) on the impact of Ibex Breast's AI on patient outcomes and health economics. Join us Tuesday, July 22nd at the International Health Economics

"Collaboration with these companies allows us to do our work in a high quality, efficient environment, adapted to current needs," says Dr. Jose Echeveste. We're honored to have Ibex's AI now live at the @ClinicaNavarra & proud to partner with @BarcoHealth and @Roche to provide a

Ibex's mission is to ensure every patients has trusted cancer diagnostics. Our 2024 Patient Insight Report revealed 62% of Americans are concerned that they or a loved one will be diagnosed with cancer in the near future, and 89% of respondents reported a need for better

Learn more:

The Ibex team around the globe is growing! 🚀 🌎 We're looking for mission-driven individuals to join us in ensuring every patient has trusted cancer diagnostics. We currently have open roles in the US & Israel for:.🔹Customer operations .🔹Product management .🔹Backend

In a @KLASresearch Report, 100% of Ibex customers saw outcomes within 6 months. We're honored to support pathologists around the world w/ #AI-powered tools that assist with #cancer diagnosis. Review the complete report for more direct customer feedback:.